Cannabis-focused research and development company The Green
Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) this morning issued
an update on its operations, including its international expansion efforts,
ongoing facility construction, strategic brand development and aggressive
talent acquisition ahead of a potential uplisting to the New York Stock
Exchange. The company also highlighted the $75 million bought deal financing
that it originally announced last week. Per the update, this additional capital
will be used to advance TGOD’s rapid and strategic international expansion
plan, with the next phases of growth expected to focus on European and Latin
American markets. The company intends to utilize the funds primarily to
establish strategic product manufacturing facilities in these markets that
adhere to TGOD’s proprietary organic growing principles. Moving forward, the
company “will continue to invest in global cultivation opportunities and
technology partnerships to deliver unique and innovative forms of its premium
organic product to consumers.”
To view the full press release, visit http://ibn.fm/fJvBO
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. is a research &
development company licensed under the Access to Cannabis for Medical Purposes
Regulations (“ACMPR”) to cultivate medical cannabis. The Company carries out
its principal activities producing cannabis from its facilities in Ancaster,
Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and
Substances Act (Canada) and its regulations. The Company grows high quality,
organic cannabis with sustainable, all-natural principles. TGOD’s products are
laboratory tested to ensure patients have access to a standardized, safe and
consistent product. TGOD has a funded capacity of 170,000 kg and is building
1,382,000 sq. ft. of cultivation facilities in Ontario, Quebec and Jamaica. The
Company has developed a strategic partnership with Aurora Cannabis Inc. (TSX:
ACB) whereby Aurora has invested approximately C$78.1 million for 20% offtake
from TGOD’s local production. In addition, TGOD has raised approximately C$350
million and has over 20,000 shareholders. TGOD’s Common Shares and warrants
issued under the indenture dated November 1, 2017 trade on the TSX under the
symbol “TGOD” and “TGOD.WT”, respectively. For more information, visit the
company’s website at www.TGOD.ca
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
